Berobenatide
A Study to Learn About Safety and Effects of Once-monthly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JM)
Pfizer · Phase 3 · Recruiting · Enrollment 197
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Treatment Arm 1 | n/r | n/r | n/r | n/r | n/r |
| Placebo | n/r | n/r | n/r | n/r | n/r |
| Treatment Arm 2 | n/r | n/r | n/r | n/r | n/r |
| Treatment Arm 3 | n/r | n/r | n/r | n/r | n/r |
| Treatment Arm 4 | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.